Pharmacists can accept drugs returned from patients but must destroy, instead of using, them.
FDA Approves Merilog as Biosimilar to Insulin Aspart for Diabetes
The drug is the first rapid-acting insulin biosimilar product approved for use by the FDA, marking a significant milestone in diabetes treatment.
Pharmacists as the Authority on Ultra-High-Cost Drugs
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
Learning Sessions, Shared Decision Making Could Help Increase Vaccinations Among Older Adults
Among providers who took part in a recent study, 57% reported increased vaccination rates after implementing a quality improvement initiative.
American Pharmacies: Powering the Profession Through Leadership
Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.
Focus on What Matters: Sustaining Your Pharmacy in 2025
What are some key strategies for keeping your pharmacy thriving in 2025?
FDA Grants Fast Track Designation to Cannabis Withdrawal Syndrome Therapy
A dose response is observed with the highest dose of the drug and mitigating withdrawal symptoms for patients with cannabis use disorder.